Strange of UBS to put out another Buy after yesterday's update but with a lower price target.
It's now BUY with $4.80 target.
Notes: "The extent of progress around the CBI investigation is a key positive compared with investor expectations, UBS asserts. The loss of license appears unlikely given a focus on remediation.While additional compliance costs are larger compared with the broker's previous estimates the vendor maximum earn-out has been reduced to $14m from $101m. Buy rating unchanged. Target is reduced to $4.80 from $5.30."
Even though the price target is now lower, I guess I can't complain about $4.80
Ann: Appendix 4E and Annual Report, page-70
Add EML (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
-0.005(0.54%) |
Mkt cap ! $350.7M | |||
| Open | High | Low | Value | Volume |
| 93.5¢ | 96.0¢ | 92.0¢ | $410.3K | 435.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 26497 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 10385 | 8 |
View Market Depth
| Last trade - 12.57pm 01/08/2024 (20 minute delay) ? |
| EML (ASX) Chart |